Two med-tech companies focused on pulmonary embolism overcame their own blockages to commercialization this week. Inquis ...

With plenty of GLP-1 money to spend, Eli Lilly and Co. is buying Verve Therapeutics Inc. and its gene-editing program for ...

UK regulators on Tuesday fined 23andMe 2.31 million pounds ($3.1 million) for data privacy violations stemming from the ...

Regeneron Pharmaceuticals had previously agreed to acquire the company for $256 million. TTAM’s higher bid and added consumer protections ultimately led the board’s special committee to select it as ...

The U.K. Information Commissioner’s Office (ICO) has fined U.S.-based 23andMe £2.31 million for serious security failures ...

US stocks fell, with investors on edge as Israel and Iran continued to trade strikes against a backdrop of shifting US trade ...

"There are only a handful of people in the world who have experience in running a direct-to-consumer genetic testing company ...

In a recent investigation we took a hard look at the cybersecurity practices of major direct-to-consumer DNA testing ...

The FTSE 100 faces a stern test of its new high levels this week, with Israel-Iran tensions still running high and Tehran ...

Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.

The Information Commissioner's Office (ICO) has levied a £2.31 million ($3.13 million) penalty on the Californian company in connection with a cyberattack in 2023 that resulted in the personal ...

The stratospheric balloons fly higher than airplanes, allowing them to map large disaster areas faster and cheaper than planes or drones.